Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
- PMID: 20539843
- PMCID: PMC2882893
- DOI: 10.2147/vhrm.s5789
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
Abstract
For patients presenting with acute dyspnea, an incorrect diagnosis could increase the mortality risk. When used in the evaluation of patients with acute symptoms, brain natriuretic peptide and N-terminal pro-brain natriuretic peptide (BNP and NT-proBNP, respectively) testing is highly sensitive for the diagnosis or exclusion of acute or chronic decompensated heart failure (HF). It has been demonstrated that BNP and proBNP levels can facilitate diagnosis and guide HF therapy. Natriuretic peptide (NP) levels are strictly related with HF severity; they are particularly increased in more advanced New York Heart Association (NYHA) classes and in patients with poor outcome. Therefore elevated NP levels were found to correlate with the severity of left ventricular systolic dysfunction, right ventricular dysfunction and pressures, and left ventricular filling alterations. However, the optimal use of NP determination agrees with patient history, physical examination, and all other diagnostic tools. There are some clinical conditions (ie, obesity, renal insufficiency anemia) for which the NP measurement is not diagnostic. Algorithm building taking into consideration all clinical and echocardiographic parameters, as well as NP measurements, may lead to the earlier identification and better risk stratification of patients with chronic HF, independently from etiology.
Keywords: diagnosis; echocardiography; heart failure; natriuretic pepides.
Figures
Similar articles
-
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.Circ Heart Fail. 2020 Feb;13(2):e006541. doi: 10.1161/CIRCHEARTFAILURE.119.006541. Epub 2020 Feb 17. Circ Heart Fail. 2020. PMID: 32065760
-
[B-type natriuretic peptide and Doppler echocardiography in the diagnosis of heart failure: alternative or complementary tools?].G Ital Cardiol (Rome). 2009 Aug;10(8):545-52. G Ital Cardiol (Rome). 2009. PMID: 19771750 Review. Italian.
-
[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32. Zhonghua Er Ke Za Zhi. 2006. PMID: 17229370 Chinese.
-
Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.Am J Cardiol. 2008 Aug 15;102(4):463-8. doi: 10.1016/j.amjcard.2008.03.083. Epub 2008 May 24. Am J Cardiol. 2008. PMID: 18678307
-
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.Eur J Heart Fail. 2019 Jun;21(6):715-731. doi: 10.1002/ejhf.1494. Eur J Heart Fail. 2019. PMID: 31222929 Review.
Cited by
-
Potential diagnostic value of circulating miRNAs in HFrEF and bioinformatics analysis.Heliyon. 2024 Sep 20;10(19):e37929. doi: 10.1016/j.heliyon.2024.e37929. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386873 Free PMC article.
-
Pathogenesis and Surgical Treatment of Congenitally Corrected Transposition of the Great Arteries (ccTGA): Part III.J Clin Med. 2024 Sep 14;13(18):5461. doi: 10.3390/jcm13185461. J Clin Med. 2024. PMID: 39336948 Free PMC article. Review.
-
Pathogenesis and Surgical Treatment of Dextro-Transposition of the Great Arteries (D-TGA): Part II.J Clin Med. 2024 Aug 15;13(16):4823. doi: 10.3390/jcm13164823. J Clin Med. 2024. PMID: 39200964 Free PMC article. Review.
-
Artificial Intelligence and Its Role in Diagnosing Heart Failure: A Narrative Review.Cureus. 2024 May 5;16(5):e59661. doi: 10.7759/cureus.59661. eCollection 2024 May. Cureus. 2024. PMID: 38836155 Free PMC article. Review.
-
Advanced Nanomaterial-Based Biosensors for N-Terminal Pro-Brain Natriuretic Peptide Biomarker Detection: Progress and Future Challenges in Cardiovascular Disease Diagnostics.Nanomaterials (Basel). 2024 Jan 10;14(2):153. doi: 10.3390/nano14020153. Nanomaterials (Basel). 2024. PMID: 38251118 Free PMC article. Review.
References
-
- Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5:167–173. - PubMed
-
- Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557–573. - PubMed
-
- Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail. 2008;10:933–989. - PubMed
-
- Tsuchida K, Tanabe K. Plasma brain natriuretic peptide concentrations and the risk of cardiovascular events and death in general practice. J Cardiol. 2008;52(3):212–223. - PubMed
-
- Mohammed AA, Januzzi JL., Jr Natriuretic Peptide guided heart failure management. Curr Clin Pharmacol. 2009;4:87–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
